BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 104 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $5,000 | +25.0% | 150 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $4,000 | -33.3% | 150 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $6,000 | -14.3% | 150 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $7,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $7,000 | -12.5% | 150 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $8,000 | +166.7% | 150 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $3,000 | – | 150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |